As of Dec 15
| +0.41 / +1.33%|
The 28 analysts offering 12-month price forecasts for Bayer have a median target of 36.05, with a high estimate of 42.13 and a low estimate of 29.58. The median estimate represents a +14.98% increase from the last price of 31.35.
The current consensus among 30 polled investment analysts is to Buy stock in Bayer. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.